These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 25268942)

  • 1. A common minimal motif for the ligands of HLA-B*27 class I molecules.
    Barriga A; Lorente E; Johnstone C; Mir C; del Val M; López D
    PLoS One; 2014; 9(9):e106772. PubMed ID: 25268942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple, non-conserved, internal viral ligands naturally presented by HLA-B27 in human respiratory syncytial virus-infected cells.
    Infantes S; Lorente E; Barnea E; Beer I; Cragnolini JJ; García R; Lasala F; Jiménez M; Admon A; López D
    Mol Cell Proteomics; 2010 Jul; 9(7):1533-9. PubMed ID: 20081153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unusual viral ligand with alternative interactions is presented by HLA-Cw4 in human respiratory syncytial virus-infected cells.
    Infantes S; Lorente E; Cragnolini JJ; Ramos M; García R; Jiménez M; Iborra S; Del Val M; López D
    Immunol Cell Biol; 2011 May; 89(4):558-65. PubMed ID: 20975736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural HLA-B*2705 protein ligands with glutamine as anchor motif: implications for HLA-B27 association with spondyloarthropathy.
    Infantes S; Lorente E; Barnea E; Beer I; Barriga A; Lasala F; Jiménez M; Admon A; López D
    J Biol Chem; 2013 Apr; 288(15):10882-9. PubMed ID: 23430249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The HLA-DP peptide repertoire from human respiratory syncytial virus is focused on major structural proteins with the exception of the viral polymerase.
    Lorente E; Barnea E; Mir C; Admon A; López D
    J Proteomics; 2020 Jun; 221():103759. PubMed ID: 32244010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A viral, transporter associated with antigen processing (TAP)-independent, high affinity ligand with alternative interactions endogenously presented by the nonclassical human leukocyte antigen E class I molecule.
    Lorente E; Infantes S; Abia D; Barnea E; Beer I; García R; Lasala F; Jiménez M; Mir C; Morreale A; Admon A; López D
    J Biol Chem; 2012 Oct; 287(42):34895-34903. PubMed ID: 22927436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV-1 proteins in infected cells determine the presentation of viral peptides by HLA class I and class II molecules and the nature of the cellular and humoral antiviral immune responses--a review.
    Becker Y
    Virus Genes; 1994 Jul; 8(3):249-70. PubMed ID: 7975271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HLA-A0201 and HLA-B7 binding peptides in the EBV-encoded EBNA-1, EBNA-2 and BZLF-1 proteins detected in the MHC class I stabilization assay. Low proportion of binding motifs for several HLA class I alleles in EBNA-1.
    Stuber G; Dillner J; Modrow S; Wolf H; Székely L; Klein G; Klein E
    Int Immunol; 1995 Apr; 7(4):653-63. PubMed ID: 7547693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HLA class I molecules consistently present internal influenza epitopes.
    Wahl A; Schafer F; Bardet W; Buchli R; Air GM; Hildebrand WH
    Proc Natl Acad Sci U S A; 2009 Jan; 106(2):540-5. PubMed ID: 19122146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The viral transcription group determines the HLA class I cellular immune response against human respiratory syncytial virus.
    Johnstone C; Lorente E; Barriga A; Barnea E; Infantes S; Lemonnier FA; David CS; Admon A; López D
    Mol Cell Proteomics; 2015 Apr; 14(4):893-904. PubMed ID: 25635267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anchoring pockets in human histocompatibility complex leukocyte antigen (HLA) class I molecules: analysis of the conserved B ("45") pocket of HLA-B27.
    Buxton SE; Benjamin RJ; Clayberger C; Parham P; Krensky AM
    J Exp Med; 1992 Mar; 175(3):809-20. PubMed ID: 1371304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dengue fever virus and Japanese encephalitis virus synthetic peptides, with motifs to fit HLA class I haplotypes prevalent in human populations in endemic regions, can be used for application to skin Langerhans cells to prime antiviral CD8+ cytotoxic T cells (CTLs)--a novel approach to the protection of humans.
    Becker Y
    Virus Genes; 1994 Sep; 9(1):33-45. PubMed ID: 7871759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of endogenously presented peptides from Chlamydia trachomatis with high homology to human proteins and to a natural self-ligand of HLA-B27.
    Cragnolini JJ; de Castro JA
    Mol Cell Proteomics; 2008 Jan; 7(1):170-80. PubMed ID: 17934211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concerted in vitro trimming of viral HLA-B27-restricted ligands by human ERAP1 and ERAP2 aminopeptidases.
    Lorente E; Barriga A; Johnstone C; Mir C; Jiménez M; López D
    PLoS One; 2013; 8(11):e79596. PubMed ID: 24223975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HLA-B27 subtype polymorphism and CTL epitope choice: studies with EBV peptides link immunogenicity with stability of the B27:peptide complex.
    Brooks JM; Colbert RA; Mear JP; Leese AM; Rickinson AB
    J Immunol; 1998 Nov; 161(10):5252-9. PubMed ID: 9820497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allele-dependent similarity between viral and self-peptide presentation by HLA-B27 subtypes.
    Fiorillo MT; Rückert C; Hülsmeyer M; Sorrentino R; Saenger W; Ziegler A; Uchanska-Ziegler B
    J Biol Chem; 2005 Jan; 280(4):2962-71. PubMed ID: 15537660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Revisiting the arthritogenic peptide theory: quantitative not qualitative changes in the peptide repertoire of HLA-B27 allotypes.
    Schittenhelm RB; Sian TC; Wilmann PG; Dudek NL; Purcell AW
    Arthritis Rheumatol; 2015 Mar; 67(3):702-13. PubMed ID: 25418920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term immunity against actual poxviral HLA ligands as identified by differential stable isotope labeling.
    Meyer VS; Kastenmuller W; Gasteiger G; Franz-Wachtel M; Lamkemeyer T; Rammensee HG; Stevanovic S; Sigurdardottir D; Drexler I
    J Immunol; 2008 Nov; 181(9):6371-83. PubMed ID: 18941228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple viral ligands naturally presented by different class I molecules in transporter antigen processing-deficient vaccinia virus-infected cells.
    Lorente E; Infantes S; Barnea E; Beer I; García R; Lasala F; Jiménez M; Vilches C; Lemonnier FA; Admon A; López D
    J Virol; 2012 Jan; 86(1):527-41. PubMed ID: 22031944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Cys-67 residue of HLA-B27 influences cell surface stability, peptide specificity, and T-cell antigen presentation.
    Alvarez I; Martí M; Vázquez J; Camafeita E; Ogueta S; López de Castro JA
    J Biol Chem; 2001 Dec; 276(52):48740-7. PubMed ID: 11673468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.